754
Views
16
CrossRef citations to date
0
Altmetric
Reviews

Prevention of viral infections in patients with multiple myeloma: the role of antiviral prophylaxis and immunization

, , &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Benjamin W. Teh, Simon J. Harrison, Leon J. Worth & Monica A. Slavin. (2016) Antiviral prophylaxis for varicella zoster virus infections in patients with myeloma in the era of novel therapies. Leukemia & Lymphoma 57:7, pages 1719-1722.
Read now

Articles from other publishers (15)

Kyle Crassini & John Gibson. (2023) Pathogenesis and management of immune dysfunction secondary to B cell haematological malignancies. Internal Medicine Journal.
Crossref
Benjamin W. Teh, Gemma Reynolds, Monica A. Slavin, Louise Cooley, Matthew Roberts, Eunice Liu, Karin Thursky, Dipti Talaulikar, Peter Mollee, Ferenc Szabo, Chris Ward, Henry Chan, H. Miles Prince & Simon J. Harrison. (2023) Executive summary of consensus clinical practice guidelines for the prevention of infection in patients with multiple myeloma. Internal Medicine Journal 53:8, pages 1469-1477.
Crossref
Jessica Caro, Marc Braunstein, Louis Williams, Benedetto Bruno, David Kaminetzky, Ariel Siegel, Beatrice Razzo, Serge Alfandari, Gareth J. Morgan, Faith E. Davies & Eileen M. Boyle. (2022) Inflammation and infection in plasma cell disorders: how pathogens shape the fate of patients. Leukemia 36:3, pages 613-624.
Crossref
Catarina Geraldes, Manuel Neves, Sérgio Chacim & Fernando Leal da Costa. (2022) Practical Considerations for the Daratumumab Management in Portuguese Routine Clinical Practice: Recommendations From an Expert Panel of Hematologists. Frontiers in Oncology 11.
Crossref
Heinz Ludwig, Angela Meckl & Monika Engelhardt. (2021) Compliance With Vaccination Recommendations Among Patients With Multiple Myeloma: A Real World Experience. HemaSphere 5:7, pages e597.
Crossref
Guido Lancman, Katleen Lozada, Nida Athar, Samantha Jacobs, John Doucette, Hearn Jay Cho, Sundar Jagannath, Deepu Madduri, Samir Parekh, Shambavi Richard, Joshua Richter & Ajai Chari. (2021) Efficacy of Intravenous Immunoglobulin for Preventing Infections in Patients with Multiple Myeloma. Clinical Lymphoma Myeloma and Leukemia 21:5, pages e470-e476.
Crossref
I.L. Davydkin, Elizaveta Vladimirovna Mordvinova & T.P. Kuzmina. (2021) Infectious Complications in Multiple Myeloma under Current Epidemiological Conditions:. Clinical oncohematology 14:3, pages 386-390.
Crossref
Chenyao Lin, Hui Shen, Shuimei Zhou, Minghui Liu, Anjie Xu, Shuang Huang, Changxin Shen & Fuling Zhou. (2020) Assessment of infection in newly diagnosed multiple myeloma patients: risk factors and main characteristics. BMC Infectious Diseases 20:1.
Crossref
Giovanni Gabutti, Francesco De Motoli, Federica Sandri, Maria Vittoria Toffoletto & Armando Stefanati. (2020) Viral Respiratory Infections in Hematological Patients. Infectious Diseases and Therapy 9:3, pages 495-510.
Crossref
Asma M. Al-Jasser & Khalid Ahmed Al-Anazi. 2019. Update on Multiple Myeloma. Update on Multiple Myeloma.
Anna Aleksandrovna Novikova, G.A. Klyasova, E.O. Gribanova, V.V. Ryzhko, T.A. Tupoleva, L.P. Mendeleeva & V.G. Savchenko. (2019) Infectious Complications in Multiple Myeloma Patients Receiving Various Antitumor Regimens. Clinical oncohematology 12:2, pages 131-139.
Crossref
Benjamin W. Teh, Constantine S. Tam, Sasanka Handunnetti, Leon J. Worth & Monica A. Slavin. (2018) Infections in patients with chronic lymphocytic leukaemia: Mitigating risk in the era of targeted therapies. Blood Reviews 32:6, pages 499-507.
Crossref
A. A. Novikova, G. A. Klyasova, E. O. Gribanova, V. A. Okhmat, V. V. Ryzhko & V. G. Savchenko. (2018) Infectious complications in patients with multiple myeloma on first chemotherapy cycle. Oncohematology 13:3, pages 63-75.
Crossref
Michel Delforge & Heinz Ludwig. (2017) How I manage the toxicities of myeloma drugs. Blood 129:17, pages 2359-2367.
Crossref
Benjamin W. Teh, Simon J. Harrison, Leon J. Worth, Karin A. Thursky & Monica A. Slavin. (2016) Infection risk with immunomodulatory and proteasome inhibitor–based therapies across treatment phases for multiple myeloma: A systematic review and meta-analysis. European Journal of Cancer 67, pages 21-37.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.